Toward understanding and exploiting tumor heterogeneity
暂无分享,去创建一个
Ash A. Alizadeh | C. Mason | R. Verhaak | J. Korbel | N. Navin | M. Esteller | A. Califano | C. Caldas | C. Roberts | J. Zucman‐Rossi | P. Lichter | K. Polyak | J. Zuber | C. Swanton | A. Snyder | A. Bardelli | C. Bock | J. Zenklusen | Michael Doherty | R. Fitzgerald | L. Siu | C. Blanpain | Markus Elsner | V. Aranda | D. Pe’er | Hannah Stower | C. Borowski | Victoria Aranda | C. Roberts
[1] Ash A. Alizadeh,et al. Abstract PR09: The prognostic landscape of genes and infiltrating immune cells across human cancers , 2015 .
[2] Beatriz Bellosillo,et al. Clonal evolution and resistance to EGFR blockade in the blood of colorectal cancer patients , 2015, Nature Medicine.
[3] Charles Swanton,et al. Clinical management of breast cancer heterogeneity , 2015, Nature Reviews Clinical Oncology.
[4] Troy Guthrie,et al. Talimogene Laherparepvec Improves Durable Response Rate in Patients With Advanced Melanoma. , 2015, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[5] Allon M. Klein,et al. Droplet Barcoding for Single-Cell Transcriptomics Applied to Embryonic Stem Cells , 2015, Cell.
[6] M. Junttila,et al. Translational value of mouse models in oncology drug development , 2015, Nature Medicine.
[7] Evan Z. Macosko,et al. Highly Parallel Genome-wide Expression Profiling of Individual Cells Using Nanoliter Droplets , 2015, Cell.
[8] X. Zhuang,et al. Spatially resolved, highly multiplexed RNA profiling in single cells , 2015, Science.
[9] Aleksandra Markovets,et al. Acquired EGFR C797S mediates resistance to AZD9291 in advanced non-small cell lung cancer harboring EGFR T790M , 2015, Nature Medicine.
[10] Ash A. Alizadeh,et al. Robust enumeration of cell subsets from tissue expression profiles , 2015, Nature Methods.
[11] Kun Zhang,et al. Fluorescent in situ sequencing (FISSEQ) of RNA for gene expression profiling in intact cells and tissues , 2015, Nature Protocols.
[12] H. Ishwaran,et al. Radiation and Dual Checkpoint Blockade Activates Non-Redundant Immune Mechanisms in Cancer , 2015, Nature.
[13] S. P. Fodor,et al. Combinatorial labeling of single cells for gene expression cytometry , 2015, Science.
[14] N. McGranahan,et al. Biological and therapeutic impact of intratumor heterogeneity in cancer evolution. , 2015, Cancer cell.
[15] Siddharth S. Dey,et al. Integrated genome and transcriptome sequencing from the same cell , 2014, Nature Biotechnology.
[16] Yang Xie,et al. A community computational challenge to predict the activity of pairs of compounds , 2014, Nature Biotechnology.
[17] G. Parker,et al. Imaging Intratumor Heterogeneity: Role in Therapy Response, Resistance, and Clinical Outcome , 2014, Clinical Cancer Research.
[18] C. Caldas,et al. Cancer Core Europe: a consortium to address the cancer care-cancer research continuum challenge. , 2014, European journal of cancer.
[19] Mariano J. Alvarez,et al. Identification of Causal Genetic Drivers of Human Disease through Systems-Level Analysis of Regulatory Networks , 2014, Cell.
[20] Sheng Li,et al. Dynamic evolution of clonal epialleles revealed by methclone , 2014, Genome Biology.
[21] P. Adusumilli,et al. Cisplatin-Induced Antitumor Immunomodulation: A Review of Preclinical and Clinical Evidence , 2014, Clinical Cancer Research.
[22] Sheng Li,et al. The pivotal regulatory landscape of RNA modifications. , 2014, Annual review of genomics and human genetics.
[23] J. Buhmann,et al. Highly multiplexed imaging of tumor tissues with subcellular resolution by mass cytometry , 2014, Nature Methods.
[24] George M. Church,et al. Highly Multiplexed Subcellular RNA Sequencing in Situ , 2014, Science.
[25] J. Wolchok,et al. Localized Oncolytic Virotherapy Overcomes Systemic Tumor Resistance to Immune Checkpoint Blockade Immunotherapy , 2014, Science Translational Medicine.
[26] Sean C. Bendall,et al. Multiplexed ion beam imaging of human breast tumors , 2014, Nature Medicine.
[27] Ash A. Alizadeh,et al. An ultrasensitive method for quantitating circulating tumor DNA with broad patient coverage , 2013, Nature Medicine.
[28] Mikko I. Kettunen,et al. Magnetic resonance imaging of tumor glycolysis using hyperpolarized 13C-labeled glucose , 2013, Nature Medicine.
[29] H. Craighead,et al. Single-molecule analysis of combinatorial epigenomic states in normal and tumor cells , 2013, Proceedings of the National Academy of Sciences.
[30] Laura S. Shankman,et al. Detection of Histone Modifications at Specific Gene Loci in Single Cells in Histological Sections , 2012, Nature Methods.
[31] Daniel F. Hayes,et al. Analysis of Circulating Tumor DNA to Monitor Metastatic Breast Cancer , 2013 .
[32] Michael P Snyder,et al. Two methods for full-length RNA sequencing for low quantities of cells and single cells , 2012, Proceedings of the National Academy of Sciences.
[33] K. Polyak,et al. Intra-tumour heterogeneity: a looking glass for cancer? , 2012, Nature Reviews Cancer.
[34] Jedd D. Wolchok,et al. Immunologic correlates of the abscopal effect in a patient with melanoma. , 2012, The New England journal of medicine.
[35] C. Iacobuzio-Donahue,et al. Computational Modeling of Pancreatic Cancer Reveals Kinetics of Metastasis Suggesting Optimum Treatment Strategies , 2012, Cell.
[36] S. Horvath,et al. Global histone modification patterns predict risk of prostate cancer recurrence , 2005, Nature.